[1]
Sarma, A., Kataki, A., Rai, A., Hazarika, M., Roy, P., Kalita, M., Deka, M. and Chattopadhyay, I. 2023. Promoter Hypermethylation of ATG16L2, TFAP2A, EBF2, Calcitonin, ABL1 Kinase Domain T315I Mutation Association with Imatinib Therapy Resistance and Median Survival in CML Patients of North-East India. Asian Pacific Journal of Cancer Care. 8, 1 (Feb. 2023), 35-42. DOI:https://doi.org/10.31557/apjcc.2023.8.1.35-42.